Success Metrics

Clinical Success Rate
84.6%

Based on 55 completed trials

Completion Rate
85%(55/65)
Active Trials
17(16%)
Results Posted
40%(22 trials)
Terminated
10(10%)

Phase Distribution

Ph not_applicable
25
24%
Ph phase_3
25
24%
Ph phase_1
13
12%
Ph phase_2
31
30%
Ph phase_4
11
10%

Phase Distribution

13

Early Stage

31

Mid Stage

36

Late Stage

Phase Distribution105 total trials
Phase 1Safety & dosage
13(12.4%)
Phase 2Efficacy & side effects
31(29.5%)
Phase 3Large-scale testing
25(23.8%)
Phase 4Post-market surveillance
11(10.5%)
N/ANon-phased studies
25(23.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.6%

55 of 65 finished

Non-Completion Rate

15.4%

10 ended early

Currently Active

17

trials recruiting

Total Trials

105

all time

Status Distribution
Active(29)
Completed(55)
Terminated(10)
Other(11)

Detailed Status

Completed55
Recruiting13
Not yet recruiting12
unknown10
Terminated10
Active, not recruiting4

Development Timeline

Analytics

Development Status

Total Trials
105
Active
17
Success Rate
84.6%
Most Advanced
Phase 4

Trials by Phase

Phase 113 (12.4%)
Phase 231 (29.5%)
Phase 325 (23.8%)
Phase 411 (10.5%)
N/A25 (23.8%)

Trials by Status

suspended11%
recruiting1312%
active_not_recruiting44%
unknown1010%
not_yet_recruiting1211%
terminated1010%
completed5552%

Recent Activity

Clinical Trials (105)

Showing 20 of 105 trialsScroll for more
NCT07415655Phase 2

Modulation of Cerebral Ischemia by Albumin

Recruiting
NCT03604406Phase 2

The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept

Completed
NCT07558642Not Applicable

Effects of Stellate Ganglion Block on Delirium and Circadian Rhythm in Geriatric Intensive Care Patients

Not Yet Recruiting
NCT06655454Phase 2

Supplemental Postoperative Bupivacaine Following Non-Surgical Endodontic Treatment

Recruiting
NCT06396065Phase 3

Phase III Study of AK112 for NSCLC Patients

Active Not Recruiting
NCT07465263Phase 3

A Study to Evaluate the SYH2053 Injection in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)

Not Yet Recruiting
NCT05634876Phase 1

UB-312 in Patients With Synucleinopathies

Completed
NCT07309614Phase 3

A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma

Recruiting
NCT05184712Phase 3

Phase 3 Clinical Study of AK112 for NSCLC Patients

Active Not Recruiting
NCT05939245Not Applicable

Comparison of Plasma Neutrophil Gelatinase-Associated Lipocalin (pNGAL) Level in De-resuscitation With Furosemide Group and Control Group

Completed
NCT03818035Phase 3

A Study to Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis

Completed
NCT07353749Phase 4

Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms

Not Yet Recruiting
NCT07241520Phase 3

Phase III Clinical Trial of SHPL-49 Injection in the Treatment of Acute Ischemic Stroke

Recruiting
NCT07240922Phase 4

The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE III) Study

Recruiting
NCT01541059Phase 4

Postoperative Analgesia Following Wisdom Teeth Removal: Ropivacaine Versus Placebo

Completed
NCT03292146Phase 3

Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study

Completed
NCT06982625Not Applicable

Supra Inguinal Fascia Iliaca Block as Rescue Analgesia Following Total Hip Arthroplasty

Recruiting
NCT06847399Phase 2

Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder

Recruiting
NCT06302296Not Applicable

Evaluating the Effect of Injectable Platelet-rich Fibrin on Accelerating Orthodontic Tooth Movement

Recruiting
NCT05885737Phase 3

Phase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus

Completed

Drug Details

Intervention Type
DRUG
Total Trials
105